Further analysis of incidence of multiple myeloma among atomic-bomb survivors, 1950 to 1994
Blood Adv
.
2023 Jun 27;7(12):2807-2810.
doi: 10.1182/bloodadvances.2022009154.
Authors
Noriaki Yoshida
1
,
Megumu Fujihara
2
,
Dale L Preston
3
,
Kotaro Ozasa
4
,
Ayumi Hida
1
,
Waka Ohishi
1
,
Ritsu Sakata
4
,
Kiyohiko Mabuchi
5
Affiliations
1
Department of Clinical Studies, Radiation Effects Research Foundation, Hiroshima, Japan.
2
Department of Pathology, Hiroshima Red Cross Hospital and Atomic-bomb Survivors Hospital, Hiroshima, Japan.
3
Hirosoft International Corporation, Eureka, CA.
4
Department of Epidemiology, Radiation Effects Research Foundation, Hiroshima, Japan.
5
Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD.
PMID:
36763540
PMCID:
PMC10279540
DOI:
10.1182/bloodadvances.2022009154
No abstract available
Publication types
Research Support, Non-U.S. Gov't
MeSH terms
Humans
Incidence
Multiple Myeloma* / epidemiology
Multiple Myeloma* / etiology
Survivors